Health Leaders Media: In a surprising reversal, pharmaceutical giant Pfizer said Tuesday it would back down from planned price hikes for several dozen of its drugs amid heavy criticism from the White House.
After weathering a one-two punch Monday from the president and his Health and Human Services secretary, who took turns publicly lambasting the company, Pfizer appeared to have escaped unscathed, at least in terms of its performance on Wall Street.
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Nowi360Gov is an intelligent network of websites and e-newsletters that provides government business, policy and technology leaders with a single destination for the most important news and analysis regarding their agency strategies and initiatives.
Telephone: 202.760.2280
Toll Free: 855.i360.Gov
Fax: 202.697.5045
The most significant government policy, business, and technology news and analysis delivered to your inbox.
Subscribe Now